Literature DB >> 1824267

Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis.

Y Colin1, B Chérif-Zahar, C Le Van Kim, V Raynal, V Van Huffel, J P Cartron.   

Abstract

Several lines of evidence have previously indicated that the RhD, c, and E blood group antigens are most likely carried by three distinct but homologous red blood cell membrane proteins. To determine whether these polypeptides are encoded by one or several related genes, we have performed Southern blot analysis of genomic DNA prepared from donors of different Rh phenotypes. Using an entire Rh cDNA probe and several exon-specific probes covering the cloned gene from its 5' to 3' ends, we have shown that the Rh locus carried by the genome of RhD-positive individuals is composed of two different but strongly related genes of identical general organization whether they expressed the C or c and E or e antigens, and, surprisingly, even when they do not express these epitopes, as in the D-- phenotype. The only antigenic variation found to be associated with a consistent genomic polymorphism corresponded to the RhD-positive/RhD-negative phenotypes. Indeed, one of the two Rh genes was completely lacking when the genomes of several unrelated RhD-negative donors were analyzed. From the present study we conclude that one of the two genes of the Rh locus encodes the RhC/c and RhE/e polypeptides while the other encodes the RhD protein. The absence of any D gene and of its postulated allelic form d in the RhD-negative genome explains finally why no Rhd antigen has ever been shown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824267

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  56 in total

1.  Function of human Rh based on structure of RhCG at 2.1 A.

Authors:  Franz Gruswitz; Sarika Chaudhary; Joseph D Ho; Avner Schlessinger; Bobak Pezeshki; Chi-Min Ho; Andrej Sali; Connie M Westhoff; Robert M Stroud
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Identification of copy number variation hotspots in human populations.

Authors:  Wenqing Fu; Feng Zhang; Yi Wang; Xun Gu; Li Jin
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

3.  The fine-scale and complex architecture of human copy-number variation.

Authors:  George H Perry; Amir Ben-Dor; Anya Tsalenko; Nick Sampas; Laia Rodriguez-Revenga; Charles W Tran; Alicia Scheffer; Israel Steinfeld; Peter Tsang; N Alice Yamada; Han Soo Park; Jong-Il Kim; Jeong-Sun Seo; Zohar Yakhini; Stephen Laderman; Laurakay Bruhn; Charles Lee
Journal:  Am J Hum Genet       Date:  2008-01-24       Impact factor: 11.025

4.  Structural analysis of the RH-like blood group gene products in nonhuman primates.

Authors:  I Salvignol; P Calvas; W W Socha; Y Colin; C Le Van Kim; P Bailly; J Ruffié; J P Cartron; A Blancher
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  A recombination hot spot in the Rh genes revealed by analysis of unrelated donors with the rare D-- phenotype.

Authors:  T J Kemp; M Poulter; B Carritt
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

6.  RHD PCR of D-Negative Blood Donors.

Authors:  Franz F Wagner
Journal:  Transfus Med Hemother       Date:  2013-05-08       Impact factor: 3.747

Review 7.  The Rhesus Site.

Authors:  Franz F Wagner; Willy A Flegel
Journal:  Transfus Med Hemother       Date:  2014-09-15       Impact factor: 3.747

8.  STUDY OF WEAK D PHENOTYPE IN HETEROGENEOUS POPULATION.

Authors:  P S Dhot; Y V Machave
Journal:  Med J Armed Forces India       Date:  2017-06-26

9.  An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus.

Authors:  Edward J Hollox; Jan-Christoph Detering; Tushna Dehnugara
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

10.  Human copy number polymorphic genes.

Authors:  J A Bailey; J M Kidd; E E Eichler
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.